Related by context. All words. (Click for frequent words.) 76 Controlled Trial 75 Randomized Controlled Trial 74 Randomized Clinical Trial 74 Meta Analysis 74 Pooled Analysis 73 Unfractionated Heparin 73 Randomized Study 73 Study Evaluating 73 Multicenter Study 73 unfractionated heparin UFH 72 Stent Restenosis 71 Multicenter 71 Patients Undergoing 71 Clinical Outcome 71 Bare Metal Stents 71 Carotid Stenting 71 Relapsing Multiple Sclerosis 71 Pharmacokinetic Study 70 Oral Fingolimod 70 Insulin Glargine 70 Randomized Evaluation 70 NSABP B 70 Double Blind Randomized 70 Renal Cell Carcinoma 70 Patency 70 II Clinical Trial 70 Nebulized 70 Randomised 69 multicentre randomized 69 Acute Ischemic Stroke 69 Acute Myocardial Infarction 69 Prolongs Survival 69 Blood Pressure Lowering 69 Double Blind Placebo 69 Randomized Double Blind 69 Multicenter Trial 69 Cardiovascular Events 69 Randomized Double Blind Placebo 69 Randomized Phase III 69 Fondaparinux 69 Stent Thrombosis 69 Pegylated Liposomal Doxorubicin 69 Prospective Randomized 69 Placebo Controlled Trial 69 Elderly Patients 69 Long Term Efficacy 69 Infarct 69 Bivalirudin 69 Placebo Controlled 69 Randomized Comparison 69 Antitumor Activity 69 Adjuvant Chemotherapy 68 Randomized Controlled 68 Newly Diagnosed Multiple Myeloma 68 Novel Oral 68 Severe Sepsis 68 EURIDIS 68 Catheter Ablation 68 Previously Untreated 68 Sirolimus Eluting Stent 68 Randomized Controlled Trials 68 Adjuvant Therapy 68 Long Term Outcomes 68 Cardiovascular Outcomes 68 Patients Treated 68 Cilostazol 68 Prospective Randomized Study 68 Plus Ribavirin 68 Mycophenolate Mofetil 68 Patients Treated With 68 Metastatic Prostate Cancer 68 Preclinical Study 68 Antiplatelet 68 Prospective Multicenter 68 Cardiotoxicity 67 Thromboembolism 67 JAK Inhibitor 67 Chemoradiation 67 Sipuleucel T 67 Blind Placebo Controlled Trial 67 Epoetin Alfa 67 Stenting Trial CREST 67 Randomized Phase 67 Localized Prostate Cancer 67 Neoadjuvant 67 Myocardial Infarction Study 67 Randomized Double blind 67 Controlled Study 67 Subgroup Analysis 67 randomized multicenter trial 67 TRANSFORMS 67 Medoxomil 67 Phase 2b Study 67 efavirenz EFV 67 Hypertensive Patients 67 Relapsing Remitting Multiple Sclerosis 67 Previously Treated 67 Carotid Endarterectomy 67 Meets Primary Endpoint 67 Coronary Revascularization 67 multicenter randomized controlled 67 Clinical Trial Results 67 Autologous Stem Cell Transplantation 67 Intervention Trial 67 Neuroprotective Effects 66 Pegylated 66 Chronic Hepatitis C 66 Angiographic 66 ASTEROID 66 Safinamide 66 Heart Failure Patients 66 Paclitaxel Eluting 66 paclitaxel eluting stents 66 TAXUS ATLAS 66 Pharmacokinetic 66 Complicated Skin 66 RENAL 66 Sirolimus eluting 66 Phase III Trial 66 Oral Anticoagulant 66 Placebo Controlled Study 66 RE MODEL 66 Multicenter Randomized Double 66 Fulvestrant 66 Monotherapy 66 Gastric Cancer 66 Radical Prostatectomy 66 Multicenter Phase 66 Multicenter Randomized 66 Peginterferon 66 Enoxaparin 66 Diabetic Patients 66 Nilotinib 66 Hemodialysis Patients 66 Vitro Activity 66 J Clin 66 Intervention Effectiveness 66 Percutaneous Tibial Nerve Stimulation 66 Drug Eluting 66 Clinical Efficacy 66 Adefovir 66 Advanced Colorectal Cancer 66 Patients Receiving 66 Randomized Trials 66 Survival Benefit 66 Acute Myocardial 66 Improves Survival 66 Long Lesion 66 J Am Coll 66 Improves Outcomes 66 Statistically Significant 66 Pharmacodynamics 66 Radiofrequency Ablation 66 ritonavir boosted 66 Fracture Risk 66 Contrast Agents 66 sirolimus eluting 66 Sirolimus Eluting 66 By JENNIFER LEARN 66 Aggressive Drug Evaluation 66 Overactive Bladder 66 RECORD1 66 Randomised Trial 66 NAVISTAR R 65 Randomized Phase II 65 Systematic Review 65 Well Tolerated 65 See CLINICAL PHARMACOLOGY 65 Brain Metastases 65 Autologous 65 Progenitor Cells 65 Orally Active 65 Capecitabine 65 Relapsed Refractory 65 Postmenopausal Women 65 Cognitive Function 65 Carotid Revascularization Endarterectomy vs. 65 Dual Antiplatelet Therapy 65 Intracoronary 65 Trial Evaluating 65 Treatment Regimens 65 Clinical Evaluation 65 multicenter phase 65 Benign Prostatic Hyperplasia 65 MR Angiography 65 ACCOMPLISH 65 Glatiramer Acetate 65 fosbretabulin 65 CLARITY TIMI 65 Knee Osteoarthritis 65 Is Well Tolerated 65 #:#-# [031] 65 Corticosteroid 65 Fluorouracil 65 Treatment Naive 65 iodixanol 65 Val HeFT 65 Prostate Cancer Recurrence 65 Relapsed Multiple Myeloma 65 Antiviral Activity 65 Severe Asthma 65 Pediatric Patients 65 Shows Promising 65 Pegylated Interferon 65 Renal Artery 65 Myocardial Perfusion Imaging 65 Stenting 65 Antigen Specific 65 Anthracycline 65 Platelet Inhibition 65 renal artery stenting 65 Phase 2b Trial 65 Subcutaneous 65 Castration Resistant Prostate Cancer 65 Prevent Stroke 65 Dendritic Cells 65 Colorectal Cancer Patients 65 Node Positive 65 Surgical Treatment 65 Nymox NX 65 Endothelial Function 65 phase IIIb 65 Eur J 65 RAVEL 64 Follicular Lymphoma 64 Intervention Effectiveness CATIE 64 Rheumatoid Arthritis Patients 64 Combination Treatment 64 Fixed Dose 64 Stenting Trial 64 Ranolazine 64 Stent Implantation 64 Investigational Drug 64 Non Inferiority 64 Bone Mineral Density 64 Protease Inhibitors 64 Nucleoside 64 Chronic Hepatitis B 64 Myocardial Ischemia 64 Telmisartan 64 Allogeneic 64 Hormone Refractory Prostate Cancer 64 Kidney Function 64 Kidney Transplant Recipients 64 Tocilizumab 64 COPERNICUS 64 Metastatic Melanoma 64 Left Ventricular Dysfunction 64 Intravascular 64 Advanced Prostate Cancer 64 Free Full Text 64 Skeletal Muscle 64 Clinical Trial Evaluating 64 Myeloma Patients 64 Tumor Response 64 Cardiol 64 Ambulatory Blood Pressure 64 Coronary Angiography 64 Infarction 64 Proves Effective 64 IN PATIENTS WITH 64 Percutaneous Coronary Intervention 64 Investigational Compound 64 Randomized Trial 64 Ziprasidone 64 abacavir Ziagen 64 Randomized 64 Arch Neurol 64 STENT 64 Proven Effective 64 Tyrosine Kinase Inhibitor 64 sirolimus eluting stents 64 Left Ventricular 64 RE LY 64 Metastatic Renal Cell Carcinoma 64 Eluting Stent 64 Trandolapril 64 Treatment Naive HIV 64 Doxil ® 64 abacavir lamivudine 64 Solid Tumors 64 Improved Survival 64 multicenter randomized 64 Kidney Transplant Patients 64 Total Knee Arthroplasty 64 Coronary Arteries 64 Advanced Renal Cell 64 Antiviral Therapy 64 Acute Coronary Syndromes 64 randomized multicenter 64 Aneurysm Repair 64 Chronic Heart Failure 64 Clostridium difficile Infection 64 Prognostic Significance 64 TO AVOID PREGNANCY WHILE 64 Phase 2a Clinical Trial 64 Unresectable 64 Histologic 64 registrational Phase 64 Intracranial Aneurysms 64 Combination Therapy 64 TMC# C# 64 Recurrent Breast Cancer 64 Anticancer Drugs 64 prospective multicenter 64 Orthostatic Hypotension 64 Tolerability 64 nondiabetic patients 64 Beneficial Effects 64 Non Alcoholic Steatohepatitis 64 Peginterferon Alfa 2a 64 Safety Tolerability 64 Cystectomy 64 Clinical Antipsychotic Trials 64 Anticancer Drug 64 Tiotropium 64 Randomized Clinical Trials 64 Drug Eluting Stents 64 Pharmacokinetics PK 63 Treatment Experienced 63 multicenter multinational 63 GOUT 63 Implantable Defibrillator 63 Non Responders 63 PREDICTIVE 63 Endarterectomy 63 Patients Enrolled 63 sirolimus eluting stent 63 Attenuates 63 Phase IIb Trial 63 Venous Thromboembolism 63 Thrombolysis 63 PEG IFN 63 Phase III Clinical Trial 63 Anticoagulant 63 Study Showed 63 Diabetic Neuropathy 63 BERKELEY CA UroToday.com 63 Eluting 63 Immunosuppression 63 Carotid 63 multicenter randomized placebo controlled 63 prospective multicenter randomized 63 Initiated Phase 63 Partial Nephrectomy 63 Liver Failure 63 Sustained Efficacy 63 Antitumor 63 Partial Onset Seizures 63 Hepatocellular Carcinoma 63 Antihypertensive 63 Radiation Dose 63 Dose Ranging Study 63 Bare Metal Stent 63 Lung Cancer Trial 63 Randomised Controlled Trial 63 Cyclophosphamide 63 Contrast Enhanced 63 Posaconazole 63 Renal Insufficiency 63 Soft Tissue Sarcoma 63 Renal Cancer 63 Low Dose 63 Chronic Constipation 63 Obese Patients 63 Curr Opin 63 Demonstrates Significant 63 zoledronate 63 Conjugate 63 HALTS 63 Study Demonstrates 63 Improve Survival 63 Recurrent Stroke 63 bivalirudin monotherapy 63 Efficacious 63 Rotavirus Vaccine 63 Sirolimus eluting Coronary Stent 63 Metastatic Colorectal Cancer 63 Ischemic Stroke 63 5 FU leucovorin 63 Patient Outcomes 63 Statin Therapy 63 Aggressive Reduction 63 HCV SPRINT 63 multicenter randomized clinical 63 Treatment Naïve Patients 63 Investigational Agent 63 Hormone Receptor Positive 63 prospective multicentre 63 Transdermal Patch 63 Critical Limb Ischemia CLI 63 #:#-# [023] 63 Single Dose 63 Renal Tumors 63 Valsartan 63 Significantly Improved 63 liposomal amphotericin B 63 Telithromycin 63 Recombinant Human 63 Septic Shock 63 Glycemic Control 63 Increased Mortality 63 Shows Efficacy 63 Clinical Relevance 63 liposome injection 63 FDA APPROVES 63 Demonstrates Efficacy 63 Adjunctive 63 Celecoxib APC trial 63 HER2 Positive Breast Cancer 63 Endovascular Repair 63 subanalysis 63 everolimus eluting stent 63 multicenter prospective 63 Mg Usa 63 Invasive Breast Cancer 63 Neoadjuvant Chemotherapy 63 CT Angiography 63 familial amyloidotic polyneuropathy FAP 63 Initiate Phase 63 Randomized Placebo Controlled 63 Androgen Deprivation Therapy 63 5 Fluorouracil 63 Cardiogenic Shock 63 Carcinomas 63 prospective randomized controlled 63 Int J Obes Relat 63 Secondary Hyperparathyroidism 63 TUMORS 63 doi #.#/fj.#-# 63 pegylated liposomal doxorubicin 63 Multicentre 63 Pivotal Study 63 Pulmonary Arterial Hypertension 63 Gastric Ulcers 63 Coronary Artery Bypass Graft 63 Adenoma Prevention 63 Cancer Incidence Mortality 63 Zoledronic Acid 63 Appears Safe 63 CARDIOVASCULAR 63 ORLive Presents 63 Refractory Angina 63 Abstract Number 63 Randomized controlled 63 Advanced Melanoma 63 Advanced Pancreatic Cancer 63 Tumor Progression 62 Contrast Agent 62 Eluting Coronary Stent System 62 Multicenter Double 62 Renal Function 62 Melphalan 62 Phase 2b Clinical Trial 62 F FDG PET 62 sunitinib Sutent 62 Aortic Stenosis 62 Decitabine 62 Lipid Levels 62 Prognostic Value 62 Fewer Side Effects 62 Biolimus A9 62 Prophylactic Treatment 62 sorafenib Nexavar 62 Demonstrates Sustained 62 Refractory Hodgkin Lymphoma 62 CLINICAL STUDIES 62 Treatment Outcome 62 Observational Study 62 Non inferiority 62 Selective Cardiac Myosin 62 Abciximab 62 Vildagliptin 62 First Patient Dosed 62 Treatment Naïve 62 Combination REOLYSIN R 62 J Allergy Clin 62 Urinary Incontinence 62 Metabolic Efficiency 62 Invasive Fungal Infections 62 Regimens 62 Tipranavir 62 Temsirolimus 62 Adalimumab 62 Clin Oncol 62 Immune Responses 62 Telbivudine 62 Molecular Weight Heparin 62 doxorubicin cyclophosphamide 62 ExTRACT TIMI 62 Pemetrexed 62 Demonstrates Positive 62 STRIDE PD 62 mycophenolate mofetil 62 Lenalidomide 62 Postmenopausal Osteoporosis 62 Interferon Beta 62 Mg Uk 62 Treated Patients 62 Adjuvant Treatment 62 ST Elevation Myocardial 62 RE LY ® 62 Natalizumab 62 Prostatic 62 prospective randomized multicenter 62 Subtypes 62 Crit Rev 62 Insulin Resistance 62 Liver Metastases 62 SORT OUT 62 ST Segment Elevation 62 Coronary Artery Bypass Surgery 62 Novel Inhibitor 62 Pivotal Trial 62 Myelodysplastic Syndrome MDS 62 Treating Chronic 62 dual endothelin receptor antagonist 62 DEFER 62 Arimidex Tamoxifen Alone 62 REALITY Trial 62 Robotic Assisted 62 Inflammatory Markers 62 multicentre randomized controlled 62 Antitumor activity 62 Neovascular Age Related Macular 62 Restenosis 62 pT2 62 Risk Stratification 62 Adjuvant Breast Cancer 62 Intravenous Equipment 62 Resistant Hypertension 62 Diabetic Nephropathy 62 J Natl Cancer Inst 62 Adjunctive Therapy 62 Oral Formulation 62 Infected Patients 62 Venous Thrombosis 62 J Pediatr 62 Acute Pancreatitis 62 FEMALES SHOULD BE ADVISED 62 Cypher Sirolimus 62 Guidelines Recommend 62 PHASE III 62 Late Breaker 62 Preclinical Data 62 evaluating tivozanib 62 Parathyroid Hormone 62 Taxus Stent 62 Naive Patients 62 Anti Tumor 62 Transurethral 62 Coronary Stent 62 Immunomedics Announces 62 complement inhibitor eculizumab 62 Oral Presentations 62 Chemotherapeutic Agents 62 gefitinib Iressa 62 #F FDG PET 62 zotarolimus eluting stent 62 HER2 Positive 62 Novel Therapeutic 62 Pivotal Phase III 62 J Am Soc 62 NCCTG N# 62 Mouse Model 62 Immunogenicity 62 Anti Tumor Activity 62 Pharmacodynamic 62 Lung Cancer Patients 62 XIENCE V PROMUS Stent 62 Renal Impairment 62 Osteoporosis Treatment 62 Surgical Procedures 62 BOLDER 62 Inhaled Corticosteroids 62 Cancer Res 62 Dasatinib 62 Darbepoetin Alfa 62 Anti TNF 62 Vaginal Gel 62 Cardiac Resynchronization 62 TROPIC 62 metastatic castration resistant 62 Carvedilol 62 Laryngeal Cancer 62 J Nutr 62 Bosutinib 62 ACE Inhibitors 62 SYNERGY Stent 62 CYPHER R Sirolimus Eluting 62 Blood Pressure Monitoring 62 Demonstrates Potential 62 fluvastatin 62 Bevacizumab 62 #:#-# [033] 62 Edge STudy 62 Phospholipase A2 62 Thiazolidinediones 62 Novel Method 62 Endeavor Drug Eluting 62 Targeted Therapy 61 THAT ARE DIFFICULT TO 61 Mortality Risk 61 #-# Full Text 61 alfuzosin 61 Genotypes 61 Coronary Syndromes 61 Aliskiren 61 Myocardial Infarction 61 Fludarabine 61 Novel Mechanism 61 Fungal Infections 61 PROTEGE 61 NATRECOR ® 61 Atypical Antipsychotic 61 Heterozygous Familial Hypercholesterolemia 61 Low Density Lipoprotein Cholesterol 61 Raloxifene Evaluation MORE 61 Hepatitis C Genotype 61 candesartan cilexetil 61 Stent Coating 61 Drug Candidate 61 Demonstrate Significant 61 Coronary Artery Calcium 61 Ranibizumab 61 Phase Ib Clinical Trial 61 bevacizumab Avastin R 61 Potent Inhibitor 61 somatostatin analog 61 Daptomycin 61 Circulating Tumor Cells 61 recurrent GBM 61 Oligonucleotides 61 alfa 2a 61 Sandostatin R 61 Aflibercept 61 Confirms Efficacy 61 Estrogen Receptor 61 Prognostic Factors 61 Therapeutic Efficacy 61 noninferior 61 pan HDAC inhibitor 61 tirofiban 61 NMIBC 61 LENALIDOMIDE 61 icatibant 61 Abstract Full Text 61 #:#-# [029] 61 Phase III Pivotal Trial 61 Antipsychotic Medications 61 Microspheres 61 relapsed MM 61 Demonstrated Significant 61 Systolic Blood Pressure 61 Improve Outcomes 61 Unstable Angina 61 Systemic Sclerosis 61 CAUTIONS 61 Systolic Hypertension 61 Moxifloxacin 61 Mimetics 61 RE LY trial 61 Lupus Nephritis 61 Thrombus Aspiration 61 Dermatol 61 mg BID dose 61 prospective nonrandomized 61 Novel Antibiotic 61 Artery Disease 61 treat benign prostatic 61 CLINICAL PHARMACOLOGY 61 Gynecol 61 Phase III Clinical Trials 61 Nat Clin Pract 61 Nicotine Vaccine 61 nonrandomized 61 Randomised Study 61 Linagliptin 61 Atypical Hemolytic Uremic Syndrome 61 Inflammatory Pain 61 carotid artery stenting CAS 61 Stereotactic Body Radiation Therapy 61 Completes Enrollment 61 Clinical Outcomes 61 Deforolimus 61 Intracerebral Hemorrhage 61 #:#-# [007] 61 Embolic Protection Device 61 Potent Antiviral Activity 61 XIENCE TM 61 Hospital Acquired Pneumonia 61 J Clin Endocrinol Metab 61 Pulmonary Vein Isolation 61 pegylated interferon alfa 2b 61 Dose Escalation 61 rosuvastatin Crestor 61 Serious Infections 61 lispro 61 PEGINTRON TM 61 Tigecycline 61 ribavirin RBV 61 Hepatitis B Vaccine 61 active comparator 61 ROCKET AF 61 Am J Clin 61 Proc Am Soc 61 Androgen Receptor 61 Am Soc Nephrol 61 Drug Eluting Coronary Stent 61 Receives Orphan Drug Designation 61 Thoracic Endoprosthesis 61 vs. Angiography 61 HYPERTENSION 61 Cutaneous T 61 GISSI 61 Pivotal Clinical Trial 61 multicenter placebo controlled 61 Dose Response 61 Spectrum Pharmaceuticals Announces 61 Lung Tumors 61 HEART FAILURE 61 Breast Cancers 61 #:#-# [035] 61 Bioavailability 61 GP IIb IIIa inhibitors 61 Degarelix 61 CANCIDAS 61 BRIM2 61 Aortic Valve Replacement 61 Placebo controlled 61 V Everolimus Eluting Coronary 61 Treatment Naive Patients 61 TLUS 61 Endovascular Treatment 61 dimeglumine 61 Protein Expression 61 Prolongs Life 61 Medullary Thyroid Cancer 61 CALGB # [002] 61 metastatic malignant 61 Digital Mammographic Imaging 61 Intravesical 61 5alpha reductase 61 Histopathological 61 Pharmacokinetics 61 Bucindolol 61 Eculizumab 61 ECASS 61 Nesiritide 61 PRECISE 61 Phase III Trials 61 는 의 61 chemoradiation therapy 61 APRICOT 61 Ureteral 61 Left Ventricular Hypertrophy 61 Dosed 61 prucalopride 61 Kinase Inhibitor 61 Stable Angina 61 mcg QD 61 abstr 61 CLINICAL TRIAL 61 Oral Mucositis 61 PKC# 61 Nephrol 61 J Am Acad 61 Chronic Bronchitis 61 Poster Presentations 61 multicentre randomized double 61 Critically Ill Patients 61 Phase III AFFIRM 61 Ann Oncol 61 galiximab 61 Inflammatory Arthritis 61 metastatic neuroendocrine tumors 61 Multivessel Evaluation 61 Peripheral Arterial 61 Nephropathy 61 ARBITER 6 61 Platinol ® 61 Molecular Basis 61 Cognitive Impairment 61 Thrombotic 61 Insulin Therapy 61 Survival Rates 61 Myelodysplastic Syndromes 61 SORIN 61 Hsp# Inhibitor 61 Novel Compound 61 Therapeutic Potential 61 Anticancer Activity 61 ILLUSTRATE 61 ACTEMRA TM 61 PREZISTA ritonavir 61 Genes Predict 60 Excretion 60 Tezampanel 60 Depressive Symptoms 60 Randomized Placebo controlled 60 Epidermal Growth Factor Receptor 60 Angiotensin Converting Enzyme 60 Antifungals 60 Kinase Inhibitors 60 FDA Approvals 60 Cytotoxicity 60 oral rivaroxaban 60 REYATAZ r arm 60 MGd 60 Shown Effective 60 REMINDER ORLive Presents 60 Azacitidine 60 IN COMBINATION WITH 60 Suppl. 60 CYPHER ® Sirolimus eluting 60 Gastrointestinal Stromal Tumors 60 Breast Cancer Recurrence 60 Reduces Mortality 60 Statistical Significance 60 Cardiac Resynchronization Therapy 60 Scintigraphy 60 HBeAg negative patients 60 Paroxysmal Nocturnal Hemoglobinuria PNH 60 Kahalalide F 60 Schizophrenia Treatment 60 ST Elevation Acute 60 Comorbidities 60 Randomized Placebo Controlled Trial 60 Tumor Growth 60 RNAi Therapeutic 60 transarterial chemoembolization 60 Primary Hypercholesterolemia 60 Optical Coherence Tomography 60 Breaking Clinical Trials 60 Clinical Outcomes Utilizing Revascularization 60 docetaxel Taxotere ® 60 Vertebroplasty 60 Neoplasms 60 Synthetic Peptide 60 Clopidogrel 60 Neurosurg 60 irbesartan 60 paricalcitol 60 Malignancies 60 Activator CK # 60 Hyperlipidemia 60 CHARISMA 60 Placebo Effect 60 Cardiac Allograft Rejection 60 Breast Carcinoma 60 β blockers 60 lopinavir r 60 lopinavir r arm 60 Acute Coronary 60 Preterm Delivery 60 Demonstrates Potent 60 Psychiatric Services #:#-#,# 60 Captopril 60 Completes Patient Enrollment 60 ABLYNX 60 Phase 2a Trial 60 FOLFOX6 60 Pioglitazone 60 Male Infertility 60 Levels Linked 60 Hematological 60 Chronic Liver Disease 60 CrossRef Medline 60 Blocked Arteries 60 Controlled Clinical Trial 60 Mantle Cell Lymphoma 60 Spine Patient Outcomes 60 amifostine 60 Bone Metastases 60 Hematopoietic 60 Efficacy Study 60 Lung Cancer Survival 60 Predict Risk 60 sunitinib Sutent ® 60 Skin Lesions 60 SABCS 60 Chronic Lymphocytic Leukemia 60 Stem Cell Transplants 60 Pt Chg 60 Predict Response 60 Neovascular AMD 60 Cardiovasc 60 Occlusion 60 Attack Trial ALLHAT 60 Glucosamine Chondroitin Arthritis 60 LHRH receptor positive 60 Osteoporosis Drugs 60 Toxicol 60 Effective Than 60 nicardipine 60 transcranial Doppler ultrasound 60 #:#-# [030] 60 vincristine doxorubicin 60 Environ Health Perspect 60 plus COPEGUS 60 PEGylated anti 60 cisplatin gemcitabine 60 Drug Shows Promise 60 plus prednisone 60 Microalbuminuria 60 TRIAL OF 60 multicenter Phase III 60 oral transmucosal fentanyl citrate 60 Dose Finding 60 Neurol 60 Elitek 60 Hepatitis C Patients 60 Disease Progression 60 CCX# B 60 Viral Suppression 60 FASEB J. 60 PEDIATRICS 60 erlotinib Tarceva ® 60 Endometrial 60 deoxy 60 PROVE IT 60 Inhalation Solution 60 Thromb Haemost 60 Ultrasensitive 60 thalidomide Thalomid 60 Am J Cardiol 60 Outpatient Setting 60 Prostate Biopsy 60 Lanthanum Carbonate 60 Diastolic Heart Failure 60 Echocardiographic 60 Protease Inhibitor 60 Chronic Myeloid Leukemia 60 orally inhaled migraine 60 BENICAR HCT 60 Rivaroxaban 60 alfa 2b 60 Phase IIa Clinical Trial 60 Therapy Reduces 60 everolimus eluting stents 60 J Clin Oncol 60 Angiogenic 60 Phase IIb Clinical Trial 60 Beta Blocker 60 VICTOR E3 60 Poster Discussion 60 SPIRIT FIRST 60 Myocardial Perfusion 60 Endometrial Cancer 60 NEVO 60 Diffuse Large B 60 dose escalation clinical 60 Balloon Angioplasty 60 FASLODEX 60 Kidney Transplantation 60 epoetin alpha 60 Neuroprotection 60 Pivotal Phase 60 Pelvic Organ Prolapse 60 Immunomodulatory 60 tigecycline 60 Female Stress Urinary 60 interferon gamma 1b 60 Fibrinogen 60 Telaprevir VX 60 Ventricular Arrhythmias 60 TRUS 60 Pediatr 60 #:#-# [025] 60 PERSEUS 60 Screening Trial 60 Intravitreal 60 Versus Placebo 60 Inhibits 60 VADT 60 Ferinject R 60 CHARISMA trial 60 Beta Blockers 60 C Reactive Protein 60 sorafenib tablets 60 Relapsed 60 Humanized Anti 60 Prophylaxis 60 Bortezomib 60 Alkaline Phosphatase 60 FOLPI 60 Cardiac Biomarkers 60 Significantly Improves 60 HCV Protease Inhibitor 60 Cannabinoid 60 Flu Cy 60 Cypher Stent 60 EXPAREL ™ 60 Pharmacokinetic PK 60 Prospective Cohort Study 60 Enzyme Replacement Therapy 60 Reduced Incidence 60 RECIST Response Evaluation Criteria 60 Ultrasound Guided